Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective

Peng Yuan, Binghe Xu National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People’s Republic of ChinaCorrespondence: Binghe XuNational Cancer Center, National Clinical Re...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuan P, Xu B
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/93ca463d3c6d472ea7ed8d651f94b2a4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!